High-entropy oxides (HEOs) have attracted significant attention owing to their broad compositional tunability and high catalytic activity. However, research in this area is still in its early stages, and it is necessary to develop uniform multifunctional high-entropy nanozymes with appropriate sizes and excellent catalytic properties. In this study, we synthesized spherical high-entropy oxide composite carbon (HEO/C) nanoparticles (NPs) with a uniform distribution of particle size. The HEO/C NPs showed efficient peroxidase and catalase activities and photothermal conversion properties in the near-infrared (NIR) biological window. Compared to conventional FeO/C NPs, HEO/C NPs exhibited superior NIR-enhanced enzyme-like activities in catalytic applications. Notably, we report, for the first time, that these HEO/C NPs exhibit T/T dual-mode magnetic resonance imaging (MRI) capabilities, outperforming the single-mode T MRI performance of FeO/C NPs. The combination of enzyme-like catalytic and photothermal properties, along with advanced MRI functionality, underscores the significant potential of HEO/C nanozymes for MRI-guided multimodal tumor therapy. This study opens new avenues for the application of high-entropy nanozymes in biomedicine.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jcis.2025.02.046 | DOI Listing |
J Colloid Interface Sci
February 2025
Faculty of Chemistry, Northeast Normal University, 5268 Renmin Street, Changchun, Jilin 130024, PR China.
High-entropy oxides (HEOs) have attracted significant attention owing to their broad compositional tunability and high catalytic activity. However, research in this area is still in its early stages, and it is necessary to develop uniform multifunctional high-entropy nanozymes with appropriate sizes and excellent catalytic properties. In this study, we synthesized spherical high-entropy oxide composite carbon (HEO/C) nanoparticles (NPs) with a uniform distribution of particle size.
View Article and Find Full Text PDFSens Actuators B Chem
April 2023
Department of Chemical Engineering (BK21 FOUR Integrated Engineering Program), Kyung Hee University, Yongin 17104, South Korea.
Coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has threatened public health globally, and the emergence of viral variants has exacerbated an already precarious situation. To prevent further spread of the virus and determine government action required for virus control, accurate and rapid immunoassays for SARS-CoV-2 diagnosis are urgently needed. In this study, we generated monoclonal antibodies (mAbs) against the SARS-CoV-2 nucleocapsid protein (NP), compared their reactivity using an enzyme-linked immunosorbent assay (ELISA), and selected four mAbs designated 1G6, 3E10, 3F10, and 5B6 which have higher reactivity to NP and viral lysates of SARS-CoV-2 than other mAbs.
View Article and Find Full Text PDFPolymers (Basel)
February 2022
Department of Plastic and Reconstructive Surgery, Seoul National University Bundang Hospital, Seongnam 13620, Korea.
Hydrocolloid dressings are an important method for accelerating wound healing. A combination of a hydrocolloid and nanoparticles (NPs), such as gold (Au), improves the wound healing rate, but Au-NPs are expensive and unable to block ultraviolet (UV) light. Herein, we combined zinc oxide nanoparticles (ZnO-NPs) with hydrocolloids for a less expensive and more effective UV-blocking treatment of wounds.
View Article and Find Full Text PDFJ Microbiol Biotechnol
May 2018
Infectious Disease Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 34141, Republic of Korea.
Influenza, which is a highly contagious disease caused by the influenza A virus, continues to be a major health concern worldwide. Although the accurate and early diagnosis of influenza virus infection is important for controlling the spread of this disease and rapidly initiating antiviral therapy, the current influenza diagnostic kits are limited by their low sensitivity. In this study, we developed several new influenza nucleoprotein (NP)-specific monoclonal antibodies (mAbs) and compared their sensitivity and specificity of those with commercially available anti-NP mAbs.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!